Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon, Korea.
Curr Opin Allergy Clin Immunol. 2013 Apr;13(2):125-31. doi: 10.1097/ACI.0b013e32835e0322.
Diisocyanates are the most common cause of occupational asthma in many industrialized countries, and various pathogenic mechanisms have been suggested to be involved. Occupational asthma causes airway remodeling unless diagnosed and treated within a proper time frame. However, treatment modalities are limited because of an insufficient understanding regarding underlying pathogenic mechanisms.
Several immunological and nonimmunological mechanisms have been suggested, indicating that the pathogenesis of occupational asthma may be more complex than other types of asthma. Airway epithelial cells are the first to encounter diisocyanates and orchestrate various responses, such as cytokine release, oxidative stress generation, and autoantibody formation. Some evidence supports the involvement of adaptive immune responses. Additional evidence suggests that other mechanisms are involved in diisocyanate-induced occupational asthma. One such candidate mechanism is oxidative stress. Oxidative stress has been shown to trigger and aid in the development of diisocyanate-induced occupational asthma in human samples and genetic studies, and some therapeutic trials were performed based on this finding.
Diisocyanate-induced occupational asthma may be caused by a complex interaction of innate and adaptive immune responses. The knowledge presented in this review may help lead to the development of new treatment modalities through an increased understanding of occupational asthma pathogenesis.
二异氰酸酯是许多工业化国家职业性哮喘的最常见病因,涉及多种发病机制。职业性哮喘会导致气道重塑,除非在适当的时间内进行诊断和治疗。然而,由于对潜在发病机制的了解不足,治疗方法有限。
已经提出了几种免疫和非免疫机制,表明职业性哮喘的发病机制可能比其他类型的哮喘更为复杂。气道上皮细胞是首先接触二异氰酸酯并协调各种反应的细胞,如细胞因子释放、氧化应激产生和自身抗体形成。一些证据支持适应性免疫反应的参与。此外,还有证据表明其他机制参与了二异氰酸酯引起的职业性哮喘。一个这样的候选机制是氧化应激。氧化应激已被证明可以触发和促进人类样本和遗传研究中二异氰酸酯引起的职业性哮喘的发展,并且根据这一发现进行了一些治疗试验。
二异氰酸酯引起的职业性哮喘可能是由先天和适应性免疫反应的复杂相互作用引起的。本综述中提出的知识可能有助于通过增加对职业性哮喘发病机制的理解,开发新的治疗方法。